We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01504152
Recruitment Status : Completed
First Posted : January 5, 2012
Last Update Posted : July 12, 2013
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.

Condition or disease Intervention/treatment
Hematopoietic Stem Cell Transplant Behavioral: questionnaire

Study Design

Study Type : Observational
Actual Enrollment : 519 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
Study Start Date : December 2011
Primary Completion Date : July 2013
Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
Behavioral: questionnaire
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.


Outcome Measures

Primary Outcome Measures :
  1. prevalence of international travel [ Time Frame: 2 years ]
    of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT


Secondary Outcome Measures :
  1. international travel was during a high-risk specific period [ Time Frame: 2 years ]
    Proportion of patients traveling to destinations that are at high risk areas for infections

  2. patients that sought pre-travel health advice [ Time Frame: 2 years ]
    among those who traveled to high risk areas for infections

  3. travelers that becomes ill and required medical attention [ Time Frame: 2 years ]
    during or after return from international travel.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who received HSCT at MSKCC between 2005-2010 and were alive after the first year after HSCT.
Criteria

Inclusion Criteria:

  • Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010.
  • Age at HSCT ≥ 18 years
  • Permanent mailing address in the United States of America

Exclusion Criteria:

  • Subject unable to fill the questionnaire due to language barriers.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01504152


Locations
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Investigators
Principal Investigator: Monika Shah, MD Memorial Sloan Kettering Cancer Center
More Information

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01504152     History of Changes
Other Study ID Numbers: 11-176
First Posted: January 5, 2012    Key Record Dates
Last Update Posted: July 12, 2013
Last Verified: July 2013

Keywords provided by Memorial Sloan Kettering Cancer Center:
International travel
cancer patients
HSCT
Quality of Life
questionnaire
11-176